Rudolf Fryček’s Post

💡#ISPOREurope spotlight - Podium: Managing and reporting missing utility data for health technology assessment (HTA). UK HTA guidelines place emphasis on consideration of uncertainty and validity of results. One common source of uncertainty, particularly for utility data, is missing data. However, there are no definitive guidelines on how to manage missing utility data in UK HTA. YHEC's Neil Hansell will be delivering a podium presentation at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024, reporting the results of a study assessing multiple analytical methods for managing different types of missing utility data and providing recommended standards. For more information about YHEC's presentations at ISPOR Europe 2024, see our bespoke website: https://lnkd.in/ekSR8XBt #ISPOREurope

Last week Thursday we launched BMF Midrand's innovation series with Dr. Rethabile Melamu, PhD. Among the nuggets of wisdom, Dr Melamu reminded us that innovation is a process, typically a very long one. Because innovation happens in a system, success requires balancing various factors for speed and direction. These factors include entrepreneurial activity for experimentation (1), research & knowledge development (2), diffusion of knowledge via networks (3), guiding selection of search (4), market forming activities (5), resource mobilization (6), and advocacy & legitimacy (7). South Africa performs exceptionally well on 2 while rather weak on the balance of factors, explaining our overall poor innovation performance. When reflecting on the 7th factor, advocacy & legitimacy, I am reminded of the late Prof Calestous Juma's book on "Innovation and Its Enemies: Why People Resist New Technologies." Once again, thank you very much for being our 1st keynote speaker Dr. Rethabile Melamu, PhD. You've a set a high standard! #innovation #research #policy

Just returning from the Netherlands, where I had the opportunity to present my research at the European Economic Association (EEA) and European Association for Research in Industrial Economics (EARIE) conferences. Both events were fantastic, but one key takeaway from Ali Yurukoglu's keynote lecture at EARIE really struck a chord with me. The lecture addressed recent concerns about declining competition in U.S. markets over the past several decades. Yurukoglu challenges this argument—what if this trend is merely an artifact of how markets are defined? By adopting a more careful and consistent approach to market definition (from advertising data!), the conclusion flips on its head: markets may actually be getting more competitive overall. This insight resonated deeply with me given my own experiences grappling with the complexities of market definition pharmaceutical markets. It's a painstaking process, and I've often wondered if it would be easier to rely on existing, albeit imperfect, definitions. But learning that this meticulous work can have significant implications reaffirms that it's worth the effort. This has also got me thinking—perhaps defining markets and patterns of substitutability should be a focus for national statistical agencies. The potential social return from such an investment could be large.  Hoping that we progress in that direction.

Eyes wide open! ● which are the implications of ongoing trends in #global #trade and #value #chains? ● how can we ensure #capital #allocation supports #innovation and #investment? ● what are the costs and benefits of #industrial #policies aimed at developing strategic sectors? The Annual Research Conference 2024 (ARC2024) will explore those questions (and others) in the context of the current changeable #geopolitical panorama, bringing #researchers and #policymakers in Ispra, Italy, from 21-22 November 2024.

Are you interested in #Research and #Innovation ? Let's come to Ispra (Varese, Italy) on 21 and 22 november to discuss your topics with me or with several members mentioned in this post by EU Science, Research and Innovation here https://lnkd.in/d7vjFg7D

Thanks to the Swiss National Science Foundation SNSF for inviting James Morris to participate in today's discussion during #RoR24, and to share the important connections between international reform efforts like the Coalition for Advancing Research Assessment and research-on-research. Research assessment processes shape every aspect of our research systems. When policy and practice changes are thoughtfully designed and informed, they can: ✅ Enhance research quality ✅ Foster the right conditions for talented individuals to thrive ✅ Drive the evolution of positive research cultures. However, if changes are not carefully considered, they risk unintended consequences—affecting the quality of research and the attractiveness of research careers. Research-on-research plays a pivotal role here. It supports innovative pilots and experiments that generate valuable insights, inform policies, and create an evidence base to benefit all research stakeholders. Sharing these outputs as openly as possible is crucial, enabling evidence-informed conditions for reform initiatives like #CoARA, which itself provides a platform for sharing and mutual learning. At Science Europe, we emphasise the importance of transparency, open communication of pilot outcomes, and alignment with shared values. Together, we can create meaningful, evidence-based reforms that support a vibrant research ecosystem. 🔍Find out more about Science Europe’s values and commitment to improving research cultures here: bit.ly/48OEarh Photo: Courtesy Swiss National Science Foundation

I would like to echo these words of Kris Sterkens and Anouk De Vroey. Competitiveness is a delicate interplay between different industrial and socioeconomic aspects and requires permanent attention both at the European and Belgian level. The (bio)pharmaceutical industry is highly regulated through specific legislation and therefore deserves a tailored approach to safeguard the sector's competitiveness #pharmavalley #Belgium #EU

We’re proud to share the success of another Director & Executive Forum, held in Melbourne last night in collaboration with MinterEllison. Our keynote speaker, Professor The Hon Greg Hunt, Former Federal Health Minister and Honorary Enterprise Professor at the University of Melbourne, shared his perspective on the future of healthcare, covering potential opportunities and mega trends. Examining current trends, Greg shed light on how the pandemic has changed the healthcare landscape and how emerging technology such as AI and genomics creates opportunities in Australian and global healthcare. Continuing the healthcare theme, James Hutton, MinterEllison Partner and Head of Life Sciences, highlighted how integrated precincts in Australia bring together stakeholders to drive innovation, research, and commercialisation through shared resources and expertise. MST Financial’s Investment Strategist, Hasan Tevfik, rounded out the presentations with his market outlook for 2025, discussing the implications of a Trumpian presidency, higher-for-longer bond yields, RBA rate cuts, and opportunities in quality commodity producers. We extend our gratitude to our partners, clients, and corporates whose participation and support contributed to the event's success. A special thank you once again to MinterEllison for hosting such a fantastic event. #MSTFinancial #MinterEllison #Melbourne #networking #finance #investing #economy #australianeconomy #research #healthcare #lifesciences #technology #biotech

We believe that developing your market access and pricing strategy starts with your data and should be a part of your evidence generation and communication strategic plans from the very start. However, no matter where you are in your commercialization and communication journey, we can help you craft your messaging to ensure life-transforming treatments get to the people who need them the most.

Science System Advisory Group (SSAG) review for NZ One of the initiatives that the Hon Judith Collins has been central in getting moving is a wide ranging review into the science and innovation potential across the motu and the barriers to moving forward. These opportunities need to be taken and are a chance for our industry and those involved across the science sectors to outline the challenges but also to come up with the solutions to take advantage of the undoubted ability within our science community. From a medical science perspective the current fragmented and difficult regulatory and competitive funding environment makes translational research to diagnostics a very difficult proposition. Many of us live and breath the barriers every day under the constraints that hold back so much potential positive advancement across the health sector. This is a perfect opportunity for individuals and industry stakeholders to identify the barriers and put solutions in front of the review committee. I encourage strong evidence based submissions with examples of how to progress your current challenges. This is not designed as a whinge fest but obviously honesty and truth around the current barriers will help the review panel to assess the current state to get a feel for the situation and the pathway to best harness and utilise the ability within our science sectors. These opportunities to be part of such a high profile review need to be taken. The initial submissions close on May 17th so make sure you all get your say! - Science System Advisory Group (ssag.org.nz)